AroCell AB (publ) In
AroCell AB (publ) Interim Report 1st January to 31st March 2019
May 16, 2019 02:00 ET | AroCell AB
Word from the CEO “Biomarkers will play an increasingly important role in how we identify and follow up treatments for patients with cancer in the coming years. The development of an increased...
AroCell AB (publ) De
AroCell AB (publ) Delårsrapport 1 januari – 31 mars 2019
May 16, 2019 02:00 ET | AroCell AB
VD-ORD ”Biomarkörer kommer spela en allt större roll i hur vi identifierar och följer upp behandlingar av patienter med cancer de kommande åren.  Utvecklingen kring ökad individanpassning drivs av...
AroCell and Corgenix
AroCell and Corgenix establish the measurement of Thymidine Kinase 1 using AroCell TK 210 ELISA in a CLIA-lab in the USA
April 15, 2019 02:00 ET | AroCell AB
AroCell AB (AROC NASDAQ Stockholm) announce today, in collaboration with Corgenix (Corgenix Inc., Colorado USA) that the AroCell TK 210 ELISA kit has been validated and approved for Thymidine Kinase 1...
AroCell inleder sama
AroCell inleder samarbete med Corgenix och erbjuder analys av Tymidinkinas 1 med hjälp av AroCell TK 210 ELISA i USA
April 15, 2019 02:00 ET | AroCell AB
AroCell AB (AROC NASDAQ Stockholm) tillkännager idag, i ett samarbete med Corgenix (Corgenix Inc., Colorado USA) att AroCell TK 210 ELISA-kit har validerats och godkänts för Tymidinkinas 1 (TK1)...
Cyclacel Pharmaceuticals logo
Cyclacel Announces Presentation of Phase 1 Data of Sapacitabine Regimen in Patients With BRCA Mutant Breast Cancer at AACR 2019
April 01, 2019 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals logo
Cyclacel Announces Abstracts Selected for Presentation at the American Association for Cancer Research Annual Meeting 2019
March 05, 2019 07:00 ET | Cyclacel
BERKELEY HEIGHTS, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing innovative...
Abstract from AroCel
Abstract from AroCell accepted for poster presentation during AACR 2019
February 28, 2019 04:30 ET | AroCell AB
An abstract from AroCell has been accepted for poster presentation on the American Association of Cancer Research 2019 (AACR 2019) held from March 29 to April 3 in Atlanta, Georgia, USA. The Study...
Abstract från AroCel
Abstract från AroCell accepterad för posterpresentation under AACR 2019
February 28, 2019 04:30 ET | AroCell AB
Ett abstract från AroCell har accepterats för posterpresentation på American Association of cancer Research 2019 (AACR 2019) som hålls mellan 29 mars och 3 april i Atlanta, Georgia, USA. Studien...